Studies have also shown that AZGP1 inhibited EMT in hepatocellular carcinoma by blocking the TGF-β1/ERK2 pathway [25] and TGF-β1/ERK 2-induced EMT in pancreatic cancer [24]. This evidence concerns the gene MAPK1 and hepatocellular carcinoma.